Mehryar Zargari
- Clinical Biochemistry top 5%
- Paraoxonase enzyme and polymorphisms 8
- Nephrology top 10%
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 4
- Multiple Sclerosis Research Studies 2
- Pharmacology top 10%
- Apelin-related biomedical research 3
-
- Genomics, phytochemicals, and oxidative stress 4
- Glycosylation and Glycoproteins Research 2
-
- Cynara cardunculus studies 4
-
- Vitamin C and Antioxidants Research 3
- Co-authors
- Fereshteh Talebpour AmiriMohammad RamezaniRezvan Yazdian‐RobatiSeyed Mohammad TaghdisiFatemeh OroojalianKhalil AbnousPayam BayatSeyed Jalal Hosseinimehr
In The Last Decade
Mehryar Zargari
47 papers receiving 909 citations
Peers
Comparison fields: 5 of 102
- Clinical Biochemistry 77
- Nephrology 74
- Pathology and Forensic Medicine 141
- Pharmacology 49
- Molecular Biology 383
Countries citing papers authored by Mehryar Zargari
This map shows the geographic impact of Mehryar Zargari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehryar Zargari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehryar Zargari more than expected).
Fields of papers citing papers by Mehryar Zargari
This network shows the impact of papers produced by Mehryar Zargari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehryar Zargari. The network helps show where Mehryar Zargari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehryar Zargari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 38 | |
| 8 | 2020 | 10 | |
| 9 | Evaluation of the Salivary Total Antioxidant Capacity and Lipid Peroxidation Status in Type 2 Diabetes Mellitus Patients | 2018 | 1 |
| 10 | 2018 | 28 | |
| 11 | 2017 | 66 | |
| 12 | Clinical, Biochemical and Genetic Analysis of Biotinidase Deficiency in Iranian Population. | 2016 | 3 |
| 13 | Association of Uric Acid with Antioxidant Capacity of Plasma in Patients with Type 2 Diabetic Nephropathy | 2015 | 1 |
| 14 | 2014 | 17 | |
| 15 | Protective Effect of Curcumin on the Superoxide Dismutase and Catalase Activity in Kidney of Acetaminophen-exposed Rats | 2013 | 6 |
| 16 | PROTECTIVE EFFECT OF L-CARNITINE ON LEVEL OF MALONDIALDEHYDE IN DIAZINON-INDUCED LIPID PEROXIDATION IN RATS | 2013 | 2 |
| 17 | 2010 | 59 | |
| 18 | 2010 | 20 | |
| 19 | 2009 | 13 | |
| 20 | 2006 | 34 |
About Mehryar Zargari
Mehryar Zargari is a scholar working on Clinical Biochemistry, Nephrology, Pharmacology, Pathology and Forensic Medicine and Nutrition and Dietetics, having authored 52 papers that have together received 925 indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (8 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Cynara cardunculus studies (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Apelin-related biomedical research (3 papers), Vitamin C and Antioxidants Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (77 citations), Nephrology (74 citations), Pathology and Forensic Medicine (141 citations), Pharmacology (49 citations) and Molecular Biology (383 citations). Mehryar Zargari has collaborated with scholars based in Iran and Sweden. Frequent co-authors include Fereshteh Talebpour Amiri, Mohammad Ramezani, Rezvan Yazdian‐Robati, Seyed Mohammad Taghdisi, Fatemeh Oroojalian, Khalil Abnous, Payam Bayat, Seyed Jalal Hosseinimehr, Ali Reza Khalatbary and Reza Meshkani. Their work appears in journals such as Journal of Biochemical and Molecular Toxicology, Atherosclerosis, Journal of Cellular Biochemistry, International Journal of Biological Macromolecules and Clinical and investigative medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.